BioDatomics LLC raised $150,000 out of an expected $450,000 equity offering. One investor participated to the non-brokered private placement. This is the first known US offering initiated by the company. Lab7 Systems a bioinformatics app developer is also in the market with a $400,000 debt offering.
BioDatomics developed an application designed for “omics” sciences research. They offer advanced analysis software for many types of computational biology, genetic sequencing and other DNA methods. The software was built around the BioUML Platform which has undergone years of careful development and been in operation as an Open Source platform and available commercially for over five years. it features around 400 different tools to perform analysis.
The company, located in Bethesda MD, was founded in 2012 by Maxim Mikheev (CEO). The management team includes Fedor Kolpakov (Chief Scientist Officer) and Tagir Valeev (Lead developer).